|
AP3807A
(en)
|
|
Novel heterocyclic derivatives and their use in the treatment of neurological disorders
|
|
HK1218749A1
(en)
|
|
Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
|
|
HK1168091A1
(en)
|
|
Oxazine derivatives and their use in the treatment of neurological disorders
|
|
HK1172023A1
(en)
|
|
Pyrazine derivatives and their use in the treatment of neurological disorders
|
|
IL232256A0
(en)
|
|
Novel purine derivatives and their use in the treatment of disease
|
|
HK1180320A1
(en)
|
|
Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd
|
|
HK1180322A1
(en)
|
|
Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd
|
|
IL223286A0
(en)
|
|
Piperidine derivatives and their use for the treatment of metabolic disorders
|
|
PT3004108T
(en)
|
|
Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease
|
|
HK1207860A1
(en)
|
|
2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders 2--5---2h--3-
|
|
DK2838539T3
(en)
|
|
ESTROGENDER DERIVATIVES TO USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
|
|
PL3466425T3
(en)
|
|
Use of glutarimide derivatives in the treatment of eosinophilic diseases
|
|
IL222692A0
(en)
|
|
Piperazinotriazines as pi3k inhibitors for use in the treatment of antiproliferative disorders
|
|
ZA201503266B
(en)
|
|
Pyidone derivatives and uses thereof in the treatment of tuberculosis
|
|
RS55061B1
(en)
|
|
Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
|
|
TH134234B
(en)
|
|
Pyrazine derivatives and their use in the treatment Of normal nervous disorders
|
|
AP2015008849A0
(en)
|
|
Pyrazolopyrrolidine derivatives and their use in the treatment of disease
|